Possible international normalized ratio elevation associated with celecoxib and warfarin in an elderly psychiatric patient [8]

Journal of the American Geriatrics Society

Volumn 51, Issue 5, 2003, Pages 728-729

  Stoner, Steven C ^a,b   Lea, Jessica Wehner ^a,b   Dubisar, Beth M ^b   Farra, Cynthia ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b NW Missouri Psychiat Rehab Ctr ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; CELECOXIB; CHLORPROMAZINE; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450 2C9; GEMFIBROZIL; INSULIN; ISOPROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIOGLITAZONE; RANITIDINE; RISPERIDONE; ROFECOXIB; TAMSULOSIN; VITAMIN K GROUP; WARFARIN;

ADULT; ANEMIA; BIPOLAR DISORDER; CASE REPORT; CHRONIC PAIN; COLON OBSTRUCTION; COLOSTOMY; COMPETITIVE INHIBITION; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG WITHDRAWAL; ENANTIOMER; GERIATRIC PATIENT; HEMICOLECTOMY; HUMAN; HYPERCHOLESTEROLEMIA; INTESTINE OBSTRUCTION; LETTER; MALE; MENTAL PATIENT; MUSCLE STIFFNESS; MYALGIA; OSTEOARTHRITIS; PROSTATE HYPERTROPHY; PROTHROMBIN TIME; SCHIZOAFFECTIVE PSYCHOSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; VITAMIN K DEFICIENCY;

ANTICOAGULANTS; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROTHROMBIN TIME; PSYCHOTIC DISORDERS; PYRAZOLES; SULFONAMIDES; WARFARIN;

EID: 0038070206     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0579.2003.00228.x     Document Type: Letter

References (9)

1. Karim A, Tolber D, Piergies A et al. Celecoxib does not significantly alter the pharmacokinerics or hypoprothrombinemic effect of warfarin in healthy subjects. J Clin Pharmacol 2000;40:655-663.
2. Mersfelder TL, Stewart LR. Warfarin and celecoxib interaction. Ann Pharmacother 2000;34:325-327.
3. Schwartz JI, Bugianesi KJ, Ebel DL et al. The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin. Clin Pharmacol Ther 2000;68:626-636.
4. Linder JD, Monkemuller KF, Davis JV et al. Cyclooxygenase-2 inhibitor celecoxib. A possible cause of gastropathy and hypoprothrombinemia. South Med J 2000;93:930-932.
5. Haase KK, Rojas-Fernandez CI, Lane L et al. Potential interaction between celecoxib and warfarin. Ann Pharmacother 2000;34:666-667.
6. Celebrex (celecoxib) [package insert]. Chicago, IL: GD Searle, 1999.
7. Michalets EL. Update: Clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 1998;18:84-112.
8. Garnett WR. Clinical implications of drug interactions with coxibs. Pharmacotherapy 2001;21:1223-1232.
9. Kaplan RC, Heckbert SR, Koepsell TD et al. Risk factors for hospitalized gastrointestinal bleeding among older persons. J Am Geriatr Soc 2001;49:126-133.